REQUEST A DEMO
Total
USD $0.00
Search more companies

Iranian Parenteral & Pharmaceutical Company Public Joint Stock (Iran)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Iranian Parenteral & Pharmaceutical Company Public Joint Stock Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Iranian Parenteral & Pharmaceutical Company Public Joint Stock, located in Tehran, was established on March 23, 1335. Originally known as Don Baxter Laboratories Company, it was registered under the number 5541. After the Islamic Revolution, the company came under the National Industries Organization of Iran and changed its name to Iran Injection Products Company in October 1360. It entered the stock market in 1377. Currently, the company produces bulk injectable products such as 500cc and 1000cc serums, as well as small volume products including 5cc therapeutic vials and ophthalmic vials. They also have a tablet and capsule line. With advanced machines and production and laboratory facilities, the company is recognized as one of the most reliable in Iran's pharmaceutical industry.

Headquarters
Shahid Raja Ee St. - Emam Zadeh Abulhasan St., P.O Box: 18735-568
Tehran; Tehran; Postal Code: 1886713718

Contact Details: Purchase the Iranian Parenteral & Pharmaceutical Company Public Joint Stock report to view the information.

Website: http://www.iphco.com

Basic Information
Total Employees:
Purchase the Iranian Parenteral & Pharmaceutical Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Iranian Parenteral & Pharmaceutical Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Iranian Parenteral & Pharmaceutical Company Public Joint Stock report to view the information.
Incorporation Date:
1957
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Vice Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
27.53%
Purchase this report to view the information.
13%
Subsidiaries
Mashateb National Broadcasting Company Private Company
Mashateb National Broadcasting Company Private Company
Company Performance
Financial values in the chart are available after Iranian Parenteral & Pharmaceutical Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
35.78%
Total operating revenue
34.85%
Operating profit (EBIT)
25.81%
EBITDA
35.48%
Net Profit (Loss) for the Period
40.18%
Total assets
44.92%
Total equity
39.31%
Operating Profit Margin (ROS)
-5.27%
Net Profit Margin
1.8%
Return on Equity (ROE)
0.39%
Quick Ratio
0.12%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?